Bollimpelli, Venkata S.
Reddy, Pradeep B. J
Gangadhara, Sailaja
Charles, Tysheena P.
Burton, Samantha L.
Tharp, Gregory K. http://orcid.org/0000-0003-3075-755X
Styles, Tiffany M.
Labranche, Celia C. http://orcid.org/0000-0002-6653-6655
Smith, Justin C. http://orcid.org/0000-0001-7702-7920
Upadhyay, Amit A. http://orcid.org/0000-0002-0952-4164
Sahoo, Anusmita
Legere, Traci
Shiferaw, Ayalnesh
Velu, Vijayakumar http://orcid.org/0000-0003-4238-1924
Yu, Tianwei
Tomai, Mark
Vasilakos, John
Kasturi, Sudhir P.
Shaw, George M.
Montefiori, David http://orcid.org/0000-0003-0856-6319
Bosinger, Steven E. http://orcid.org/0000-0002-2116-5061
Kozlowski, Pamela A. http://orcid.org/0000-0001-9906-6234
Pulendran, Bali http://orcid.org/0000-0001-6517-4333
Derdeyn, Cynthia A. http://orcid.org/0000-0002-1220-513X
Hunter, Eric http://orcid.org/0000-0002-4273-8631
Amara, Rama R. http://orcid.org/0000-0002-6309-6797
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UM1 AI124436)
Emory Consortium for Innovative AIDS Research in Nonhuman Primates
Article History
Received: 19 May 2022
Accepted: 28 July 2023
First Online: 8 August 2023
Competing interests
: Rama Amara is a co-inventor of the DNA/MVA vaccine technology that has been licensed to Geovax Inc., by Emory University. The remaining authors declare no competing interests.